导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 23.30% | 191/1050 |
| 近一周 | -0.86% | 425/1104 |
| 近一月 | -5.88% | 850/1103 |
| 近一季 | -5.44% | 491/1092 |
| 近半年 | 13.57% | 224/1070 |
| 近一年 | 30.49% | 166/1018 |
| 近两年 | 92.21% | 234/926 |
| 近三年 | 64.94% | 188/834 |
| 成立以来 | 111.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.26% 247/1070 |
47.80% 237/1101 |
- - |
- - |
| 2025 | 29.18% 484/1065 |
3.89% 488/1014 |
-2.85% 884/1038 |
33.42% 310/1050 |
-4.06% 671/1065 |
| 2024 | 6.98% 359/1011 |
-4.72% 556/960 |
1.11% 240/983 |
14.05% 298/991 |
-2.63% 503/1011 |
| 2023 | -13.69% 464/952 |
0.67% 597/880 |
-4.29% 478/895 |
-8.59% 531/915 |
-2.00% 235/952 |
| 2022 | -24.24% 471/867 |
-20.51% 543/773 |
5.28% 505/806 |
-12.00% 390/845 |
2.88% 280/867 |
| 2021 | 4.68% 307/740 |
-17.37% 549/580 |
25.22% 85/659 |
6.43% 96/704 |
-4.95% 591/740 |
| 2020 | 128.81% 5/554 |
2.32% 107/419 |
36.25% 55/466 |
24.31% 21/517 |
32.04% 36/554 |
| 2019 | 48.28% 161/410 |
31.75% 280/1149 |
-4.47% 674/1231 |
5.85% 186/390 |
11.30% 124/410 |
| 2018 | -41.81% 280/349 |
- - |
- - |
- - |
-17.10% 953/1080 |
| 2017 | 1.45% 172/285 |
- - |
- - |
- - |
- - |
| 2016 | -26.28% 140/205 |
- - |
- - |
- - |
- - |
| 2015 | 47.79% 26/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银高端制造股票 VS. 东吴新产业精选股票A(580008) |